ConforMIS, Inc. (CFMS)
(Delayed Data from NSDQ)
$2.66 USD
+0.22 (9.02%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.65 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.66 USD
+0.22 (9.02%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.65 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
5 Top-Ranked Stocks to Benefit From Rising P/E Investing
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
3D Printing in Vogue: 4 MedTech Stocks to Keep an Eye On
by Sweta Jaiswal
3D printing lends a competitive edge to medical device manufacturers by enhancing efficiency and cutting down on processing time.
TransEnterix (TRXC) Soars: Stock Adds 12.7% in Session
by Zacks Equity Research
TransEnterix (TRXC) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.
5 MedTech Momentum Picks Investors Will Love
by Zacks Equity Research
In a volatile political environment, seasoned investors should focus on momentum stocks as winning bets to tide over the uncertainty.
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
5 MedTech Stocks to Buy Before Q3 Earnings
by Zacks Equity Research
The Q3 earnings season is just around the corner for the political hotspot MedTech space.
Will ConforMIS (CFMS) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in ConforMIS Inc (CFMS)
ConforMIS (CFMS) Worth a Look: Stock Jumps 13.4% in Session
by Zacks Equity Research
ConforMIS, Inc. (CFMS) shares rose over 13% in the last trading session.
ConforMIS (CFMS) Gets FDA Approval for iTotal Hip System
by Zacks Equity Research
Medical technology company, ConforMIS, Inc. (CFMS) recently announced the receipt of FDA 510(k) clearance for its primary iTotal Hip replacement system.
Why Trump Could Still Be a Threat to Medical Device Stocks
by Zacks Equity Research
The Republican healthcare bill, American Health Care Act (ACHA), which was released earlier this month with the target to repeal the Affordable Care Act (ACA), hasn't found favor with the masses.
Moving Average Crossover Alert: ConforMIS (CFMS)
by Zacks Equity Research
ConforMIS, Inc. (CFMS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
What's in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots Alliance, Inc (WBA) is slated to release first-quarter 2017 results, before the market opens on Jan 5.
MedTech Tailwinds at a Glance: Which Stocks to Buy?
by Zacks Equity Research
Positive demographic trends and new product innovation have been the vital force behind the continued uptrend of the sector???s performance.